Article

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer

2019-04-30

Abstract excerpt

Breast cancer is a global health issue. For decades, breast cancer was classified into many histological subtypes on the basis of microscopic and immunohistochemical evaluation. The discovery of many key genomic driver events involved in breast cancer carcinogenesis resulted in a better understanding of the tumor biology, the disease heterogeneity and the prognosis leading to the discovery of new modalities of tar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fd40160f-9c48-5ba4-8b3e-5f8e86a98401
DOI: 10.12688/f1000research.17542.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancerDOI 10.12688/f1000research.17542.1Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read

Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted TherapiesSemantic proximity Read

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategiesSemantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read

Pathogenesis of Triple-Negative Breast CancerSemantic proximity Read